Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).
Yugo Yamashita; Takeshi Morimoto; Nao Muraoka; Wataru Shioyama; Ryuki Chatani; Tatsuhiro Shibata; Yuji Nishimoto; Yoshito Ogihara; Kosuke Doi; Maki Oi; Taro Shiga; Daisuke Sueta; Kitae Kim; Yasuhiro Tanabe; Norimichi Koitabashi; Takuma Takada; Satoshi Ikeda; Hitoshi Nakagawa; Kengo Tsukahara; Masaaki Shoji; Jiro Sakamoto; Shinji Hisatake; Yutaka Ogino; Masashi Fujita; Naohiko Nakanishi; Tomohiro Dohke; Seiichi Hiramori; Ryuzo Nawada; Kazuhisa Kaneda; Koh Ono; Takeshi Kimura
Circulation, 2024年11月18日, 筆頭著者, 責任著者